Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China flag China · Delayed Price · Currency is CNY
8.22
-0.38 (-4.42%)
Sep 10, 2026, 12:44 PM CST

SHE:300016 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,2941,205983.55890.72765.88859.91
Revenue Growth
18.34%22.54%10.42%16.30%-10.93%3.94%
Gross Profit
565.75542.96458.97405.35400.41531.92
Operating Income
133.4987.8653.24-25-5.12127.55
Net Income
142.5292.7313.65-71.7611.28125.51
Earnings Per Share
0.260.180.03-0.150.020.26
EPS Growth
392.13%500.00%---92.31%-27.78%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Overseas
199.87132.16114.9--
Northeast China Region
75.6475.0582.3178.8993.8
North China
190.59164.92184.62168.11201.38
East China
348.13245.15219.86186.98225.18
Southern China
114.57129.7893.3657.2336.47
Central China
136.43125.45103.16109.57137.5
Northwestern Region
27.5719.2617.9217.924.01
Southwest Region
93.6880.7568.1784.58101.93
Other
18.7911.046.4262.6239.65
Total
1,205983.55890.72765.88859.91

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
882.32675.18608.23748.45766.73895.02
Total Debt
568.4506.37797.32790.72646.71575.72
Net Cash (Debt)
313.92168.81-189.09-42.28120.03319.31
Net Cash Growth
-----62.41%2.79%
Net Cash Per Share
0.570.33-0.42-0.090.210.66

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
233.31156.57163.0258.46127.81108.73
Capital Expenditures
-182.97-218.87-101.39-144.61-102.78-147.76
Free Cash Flow
50.34-62.361.63-86.1525.03-39.03
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
43.71%45.05%46.66%45.51%52.28%61.86%
Operating Margin
10.31%7.29%5.41%-2.81%-0.67%14.83%
Pretax Margin
13.87%9.00%-0.08%-11.36%-1.93%14.23%
Profit Margin
11.01%7.69%1.39%-8.06%1.47%14.60%
FCF Margin
3.89%-5.17%6.27%-9.67%3.27%-4.54%

Dividends

Fiscal YearFY 2024FY 2023FY 2022FY 2021
Period EndingDec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.050-0.0700.070
Dividend Per Share Growth
--0%16.67%
Dividend Yield
0.81%-1.09%0.78%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
33.3148.19223.42-284.2636.04
Forward PE
-19.2219.2219.2219.2219.22
P/FCF Ratio
99.37-49.49-128.15-
PS Ratio
3.863.713.103.934.195.26